Abstract
Xenoestrogens are chemically distinct industrial products potentially able to disrupt the endocrine system by mimicking the action of endogenous steroid hormones. Among such compounds, the ubiquitous environmental contaminants bisphenol A (BPA) and 4-nonylphenol (NPH) may promote adverse effects in humans triggering estrogenic signals in target tissues. Following a research program on human exposure to endocrine disruptors, we found contamination of fresh food by BPA and NPH. More important, these contaminants were found to display estrogen-like activity using as a model system the estrogen-dependent MCF7 breast cancer cells (MCF7wt); its variant named MCF7SH, which is hormone-independent but still ERα-positive, and the steroid receptor-negative human cervical carcinoma HeLa cells. In transfection experiments BPA and NPH activated in a direct manner the endogenous ERα in MCF7 wt and MCF7SH cells, as the antiestrogen hydroxytamoxifen was able to reverse both responses. Moreover, only the hormone-binding domains of ERα and ERβ expressed by chimeric proteins in HeLa cells were sufficient to elicit the transcriptional activity upon BPA and NPH treatments. Transfecting the same cell line with ERα mutants, both contaminants triggered an estrogen-like response. These transactivation properties were interestingly supported in MCF7wt cells by the autoregulation of ERα which was assessed by RT-PCR for the mRNA evaluation and by immunoblotting and immunocytochemistry for the determination of protein levels. The ability of BPA and NPH to modulate gene expression was further confirmed by the upregulation of an estrogen target gene like pS2. As a biological counterpart, concentrations of xenoestrogens eliciting transcriptional activity were able to stimulate the proliferation of MCF7wt and MCFSH cells. Only NPH at a dose likely too high to be of any physiological relevance induced a severe cytotoxicity in an ERα-independent manner as ascertained in HeLa cells. The estrogenic effects of such industrial agents together with an increasing widespread human exposure should be taken into account for the potential influence also on hormone-dependent breast cancer disease.
Similar content being viewed by others
References
Fang, H., Tong, W., Shi, L. M., et al. (2001). Chem. Res. Toxicol. 14, 280–294.
Kavlock, R. J., Daston, G. P., De Rosa, C., et al. (1996). Environ. Health Perpect. 104, 715–740.
Markey, C. M., Rubin, B. S., Soto, A. M., and Sonnenschein, C. (2003). J. Steroid Biochem. Mol. Biol. 83, 235–244.
Cooper, R. L. and Kavlock, R. J. (1997). J. Endocrinol. 152, 159–166.
Masuyama, H., Hiramatsu, Y., Kunitomi, M., Kudo, T., and MacDonald, P. N. (2000). Mol. Endocrinol. 14, 421–428.
Blume, B., Kietzmann, M., Kranke, P., Moder, M., Schrader, S., and Wahren, M. (2000). Environ. Health Stud. 36, 3–9.
Brotons, J. A., Olea-Serrano, M. F., Villalobos, M., Pedraza, V., and Olea, N. (1995). Environ. Health Perspect. 103, 608–612.
Feldman, D. (1997). Endocrinology 138, 1777–1779.
Guenther, K., Heinke, V., Thiele, B., Kleist, E., Prast, H., and Raecker, T. (2002). Environ. Sci. Technol. 36, 1676–1680.
Olea, N., Pulsar, R., Perez, P., et al. (1996). Environ. Health Perspect. 104, 298–305.
Gozzo, F. and Poupaert, J. H. (1998). J. Pharm. Belg. 53, 278–286.
Takai, Y., Tsutsumi, O., Ikezuki, Y., et al. (2000). Biochem. Biophys. Res. Commun. 270, 918–921.
Kuiper, G. G. J. M., Lemmen, J. G., Carlsson, B., et al. (1998). Endocrinology 139, 4252–4263.
Usami, M., Mitsunaga, K., and Ohno, Y. (2002). J. Steroid Biochem. Mol. Biol. 81, 47–55.
Tora, L., White, J., Brou, C., et al. (1989). Cell 59, 477–487.
Heery, D. M., Kalkhoven, E., Hoare, S., and Parker, M. G. (1997). Nature 387, 733–736.
McKenna, N. J., Lanz, R. B., and O’Malley, B. W. (1999). Endocr. Rev. 20, 321–344.
Beekman, J. M., Allan, G. F., Tsai, S. Y., Tsai, M. J., and O’Malley, B. W. (1993). Mol. Endocrinol. 7, 1266–1274.
Hall, J. M., McDonnell, D. P., and Korach, K. S. (2002). Mol. Endocrinol. 16, 469–486.
Brzozowski, A. M., Pike, A. C., Dauter, Z., et al. (1997). Nature 389, 753–758.
Feng, W., Ribeiro, R. C., Wagner, R. L., et al. (1998). Science 280, 1747–1749.
Paige, L. A., Christensen, D. J., Gron, H., et al. (1999). Proc. Natl. Acad. Sci. USA 96, 3999–4004.
Meegan, M. J., Hughes, R. B., Lloyd, D. G., Williams, D. C., and Zisterer, D. M. (2001). J. Med. Chem. 44, 1072–1084.
Buelke-Sam, J., Bryant, H. U., and Francis, P. C. (1998). Reprod. Toxicol. 12, 217–221.
Jaiyesimi, I. A., Buzdar, A. U., Decker, D. A., and Hortobagyi, G. N. (1995). J. Clin. Oncol. 13, 513–529.
Jordan, V. C. and Morrow, M. (1994). Eur. J. Cancer 30, 1714–1721.
Turner, C. H., Sato, M., and Bryant, H. U. (1994). Endocrinology 135, 2001–2005.
Dowsett, M., Johnston, S. R., Iveson, T. J., and Smith, I. E. (1995). Lancet 25, 8948.
Labrie, F., Labrie, C., Belanger, A., et al. (1999). J. Steroid Biochem. Mol. Biol. 69, 51–84.
Sibonga, J. D., Dobnig, H., Harden, R. M., and Turner, R. T. (1998). Endocrinology 139, 3736–3742.
Peterson, G. and Barnes, S. (1991). Biochem. Biophys. Res. Commun. 179, 661–667.
Adlercreutz, H., Mousavi, Y., Clark, J., et al. (1992). J. Steroid Biochem. Mol. Biol. 41, 331–337.
Maggiolini, M., Bonofiglio, D., Marsico, S., et al. (2001). Mol. Pharm. 60, 595–602.
Bergeron, R. M., Thompson, T. B., Leonard, L. S., Pluta, L., and Gaido, K. W. (1999). Mol. Cell. Endocrinol. 150, 179–187.
Gaido, K. W., Leonard, L. S., Lovell, S., et al. (1997). Toxicol. Appl. Pharmacol. 143, 205–212.
Gould, J. C., Leonard, L. S., Maness, S. C., et al. (1998). Mol. Cell. Endocrinol. 142, 203–214.
Howdeshell, K. L., Hotchkiss, A. K., Thayer, K. A., Vandenbergh, J. G., and vom Saal, F. S. (1999). Nature 401, 763–764.
Kim, H. S., Han, S. Y., Yoo, S. D., Lee, B. M., and Park, K. L. (2001). J. Toxicol. Sci. 26, 111–118.
Krishnan, A. V., Stathis, P., Permuth, S. F., Tokes, L., and Feldman, D. (1993). Endocrinology 132, 2279–2286.
Matthews, J. B., Twomey, K., and Zacharewski, T. R. (2001). Chem. Res. Toxicol. 14, 149–157.
Nagel, S. C., vom Saal, F. S., Thayer, K. A., Dhar, M. G., Boechler, M., and Welshons, W. V. (1997). Environ. Health Perspect. 105, 70–76.
Safe, S. H., Pallaroni, L., Yoon, K., et al. (2001). Reprod. Fertil. Dev. 13, 307–315.
Steinmetz, R., Brown, N. G., Allen, D. L., Bigsby, R. M., and Ben-Jonathan, N. (1997). Endocrinology 138, 1780–1786.
Steinmetz, R., Mitchner, N. A., Grant, A., Allen, D. L., Bigsby, R. M., and Ben-Jonathan, N. (1998). Endocrinology 139, 2741–2747.
vom Saal, F. S., Cooke, P. S., Buchanan, D. L., et al. (1998). Toxicol. Ind. Health 14, 239–260.
Schafer, T. E., Lapp, C. A., Hanes, C. M., Lewis, J. B., Wataha, J. C., and Schuster, G. S. (1999). J. Biomed. Mater. Res. 45, 192–197.
Soto, A. M., Justicia, H., Wray, J. W., and Sonnenschein, C. (1991). Environ. Health Perspect. 92, 167–173.
Diel, P., Olff, S., Schmidt, S., and Michna, H. (2002). J. Steroid Biochem. Mol. Biol. 80, 61–70.
Kalkhoven, E., Beraldi, E., Panno, M. L., De Winter, J. P., Thijssen, J. H., and van Der Burg, B. (1996). Int. J. Cancer 65, 682–687.
Maggiolini, M., Donzè, O., Jeannin, E., Andò, S., and Picard, D. (1999). Cancer Res. 59, 4864–4869.
Ekena, K., Weis, K. E., Katzenellenbogen, J. A., and Katzenellenbogen, B. S. (1996). J. Biol. Chem. 271, 20053–20059.
Santagati, S., Gianazza, E., Agrati, P., et al. (1997). Mol. Endocrinol. 11, 938–949.
deGraffenried, L. A., Hilsenbeck, S. G., and Fuqua, S. A. (2002). J. Steroid Biochem. Mol. Biol. 82, 7–18.
Safe, S. (2001). Vitam. Horm. 62, 231–252.
Anstead, G. M., Carlson, K. E., and Katzenellenbogen, J. A. (1997). Steroids 62, 268–303.
Dodge, J. and Jones, C. (1999). In: Estrogens and antiestrogens: physiology and mechanisms of action of estrogens and antiestrogens. Oettel, M. and Schillinger, E. (eds.). Springer-Verlag: Berlin.
Shi, L. M., Fang, H., Tong, W., et al. (2001). J. Chem. Inf. Comput. Sci. 41, 186–195.
Wijayaratne, A. L. and McDonnell, D. P. (2001). J. Biol. Chem. 276, 35684–35692.
Jennie, W. D., Aldridge, T. C., and Brooks, A. N. (1998). J. Endocrinol. 158, 11–14.
Htun, H., Holth, L. T., Walker, D., Davie, J. R., and Hager, G. L. (1999). Mol. Biol. Cell 10, 471–486.
Dauvois, S., White, R., and Parker, M. G. (1993). J. Cell Sci. 106, 1377–1388.
Rivas, A., Lacroix, M., Olea-Serrano, F., Laios, I., Leclercq, G., and Olea, N. (2002). J. Steroid Biochem. Mol. Biol. 82, 45–53.
Shim, W., Conaway, M., Masamura, S., et al. (2000). Endocrinology 141, 396–405.
Shimizu, M., Ohta, K., Matsumoto, Y., Fukuoka, M., Ohno, Y., and Ozawa, S. (2002). Toxicol. In Vivo 16, 549–556.
Atkinson, A. and Roy, D. (1995). Biochem. Biophys. Res. Commun. 210, 424–433.
Knaak, J. B. and Sullivan, L. J. (1966). Toxicol. Appl. Pharmacol. 8, 175–184.
Bunone, G., Briand, P. A., Miksicek, R. J., and Picard, D. (1996). EMBO J. 15, 2174–2183.
Webb, P., Nguyen, P., Shinsako, J., et al. (1998). Mol. Endocrinol. 12, 1605–1618.
Seipel, K., Georgiev, O., and Shaffner, W. (1992). EMBO J. 11, 4961–4968.
Maggiolini, M., Donzé, O., and Picard, D. (1999). Biol. Chem. 380, 695–697.
Brown, A. M., Jeltsch, J. M., Roberts, M., and Chambon, P. (1984). Proc. Natl. Acad. Sci. USA 81, 6344–6348.
Laborda, J. (1991). Nucleic Acids Res. 19, 3998.
Egger, D. and Bienz, K. (1994). Mol. Biotechnol. 3, 289–305.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vivacqua, A., Recchia, A.G., Fasanella, G. et al. The food contaminants bisphenol A and 4-nonylphenol act as agonists for estrogen receptor α in MCF7 breast cancer cells. Endocr 22, 275–284 (2003). https://doi.org/10.1385/ENDO:22:3:275
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/ENDO:22:3:275